Invitation to Annual Meeting of Shareholders

3/15/2000 6:36 AM EST

The Board of Directors of Active Biotech AB (publ) has today issued a
notification of the Annual General Meeting, which is to take place at
17.00 on 12 April 2000 at the Star Hotel in Lund. The notification is
published in today´s editions of Sydsvenskan, Svenska Dagbladet and Post-
och Inrikes tidningar.

ACTIVE BIOTECH AB (PUBL)

THE BOARD OF DIRECTORS

Active Biotech AB is a Swedish biotechnology company focused on the
research and development of pharmaceuticals and vaccines; our core
competence being our knowledge of the human immune system. We have a high
quality project portfolio and considerable financial resources. Important
products include Dukoral,
SBL Cholera vaccine, a vaccine against tourist diarrhoea (ETEC),
innovative drugs against MS (SAIK) and cancer (TTS). The turnover of
Active Biotech was SEK 267 million in 1999.

Active Biotech AB
Box 724, S-220 07 Lund, Sweden
Tel +46 46-19 20 00
Fax +46 46 19 20 50
E-mail  
Invitation to Annual Meeting of Shareholders in Active Biotech AB (publ)

The shareholders in Active Biotech AB (publ) are hereby invited to attend
the Annual General Meeting of Shareholders to be held at 17.00 on
Wednesday, 12 april at the Star Hotel in Lund. Following the meeting, the
shareholders are invited to Active Biotech's research installation at
Scheelevägen 22 in Lund.

NOTIFICATION

Shareholders, who wish to participate in the Annual General Meeting of
Shareholders, must

both be entered under their own names (not registered as a trustee) in
the register of shareholders maintained by Värdepapperscentralen VPC AB on
behalf of the Company, as of 2 april 2000, which means that notification
for registration at VPC must be done by Friday, 31 March 2000;

and notify the Company of their intention to participate in the Annual
General Meeting of Shareholders by no later than 16.00 on Thursday, 6
April 2000.

Notification of participation in the Annual General Meeting of
Shareholders shall be made in writing to Active Biotech AB (publ), Att.
Susanne Jönsson, P. O. Box 724, S-220 07 Lund, by telephone on +46 46 / 19
20 00, by fax on +46 46 / 19 20 50 or via e-mail  .
Upon notification the following information shall be provided: name,
personal identity number/corporate registration number, address and
telephone number, together with numbers and type(s) of shares.

In order to possess the right to participate in the Annual General Meeting
of Shareholders, shareholders whose shares are registered in trust through
a bank's trust department or individual stockbroker, must temporarily
register the shares with VPC in their own name. Such re-registration must
be completed by no later than Friday, 31 March.